Uni-Carbomer 974P / Carbomer

Inkcazelo emfutshane:

Iimveliso ze-Uni-Carbomer 974P zisetyenziswe ngempumelelo kwiimveliso ze-ophthalmic kunye nokuqulunqwa kwamayeza ukunika ukuguqulwa kwe-rheology, ukudibanisa, ukukhutshwa kweziyobisi okulawulwayo, kunye nezinye iipropati ezininzi ezizodwa.


Iinkcukacha zeMveliso

Iithegi zeMveliso

Igama lorhwebo Uni-Carbomer 974P
Inombolo yeCAS. 9003-01-04
INCI Igama Carbomer
Ulwakhiwo lweMichiza
Isicelo Iimveliso ze-Ophthalmic, ii-Pharmaceutical formulations
Iphakheji I-20kgs inet ngebhokisi yekhadibhodi ene-PE lining
Imbonakalo Umgubo omhlophe
Viscosity (20r/min, 25°C) 29,400-39,400mPa.s (0.5% isisombululo samanzi)
Ukunyibilika Amanzi anyibilikayo
Umsebenzi Iiarhente zokutyebisa
Beka ubomi kwishelufa iminyaka eyi-2
Ugcino Gcina isitya sivaliwe ngokuqinileyo kwaye kwindawo epholileyo. Gcina kude nobushushu.
Umthamo 0.2-1.0%

Isicelo

I-Uni-Carbomer 974P idibana noshicilelo lwangoku lwemonographs ilandelayo:

EUnited States Pharmacopeia/National Formulary (USP/NF) monograph yeCarbomer Homopolymer Type B (Qaphela: I-USP/NF yangaphambili igama elixhasayo lale mveliso yayiyiCarbomer 934P.)

I-European Pharmacopeia (Ph. Eur.) imonograph yeCarbomer

I-China Pharmacopoeia (PhC.) imonograph yeCarbomer B

Ipropati ye-Applicaiton

Iimveliso ze-Uni-Carbomer 974P zisetyenziswe ngempumelelo kwiimveliso ze-ophthalmic kunye nokwakhiwa kwamachiza ukunika ukuguqulwa kwe-rheology, ukudibanisa, ukukhutshwa kweziyobisi okulawulwayo, kunye nezinye iipropati ezininzi ezizodwa.

I-1) Ubuhle obufanelekileyo kunye neempawu zovakalelo-yandisa ukuthotyelwa kwesigulana ngokucaphuka okuphantsi, iifomyula ezithandekayo ngovakalelo olufanelekileyo.

I-2) I-Bioadhesion / i-Mucoadhesion- yenza ukuhanjiswa kweziyobisi ngokwandisa uqhagamshelwano lwemveliso kunye ne-biological membranes, ukuphucula ukuthotyelwa kwesigulane ngesidingo esincitshisiweyo sokulawulwa rhoqo kweziyobisi, kunye nokukhusela kunye nokuthambisa ubuso be-mucosal.

3)Ukuguqulwa kweRheology esebenzayo kunye nokujiya kwi-semisolids yezihloko


  • Ngaphambili:
  • Okulandelayo: